Table 4.
Comparison of recurrence patterns according to stage III GC patients with or without venous invasion
| Venous invasion | Univariatea | ||||
|---|---|---|---|---|---|
| N | Present | Absent | P-value | ||
| Total | 97 | 49 (51%) | 48 (49%) | 0.615 | |
| Hematogenous recurrence | 12 | 10 (10%) | 2 (2%) | 0.022 | |
| Liver | 8 | 7 (7%) | 1 (1%) | 0.021 | |
| Lung | 2 | 2 (2%) | 0 (0%) | 0.096 | |
| Bone | 2 | 1 (1%) | 1 (1%) | 0.988 | |
| Lymphatic recurrence | 12 | 7 (7%) | 5 (5%) | 0.562 | |
| Peritoneal recurrence | 34 | 18 (19%) | 16 (16%) | 0.726 | |
| Local recurrence | 4 | 1 (1%) | 3 (3%) | 0.287 | |
aKaplan-Meier method: significance was determined by the Wilcoxon test
Significant values are in bold